| Type of Material: | Thesis |
| Title: | Evaluation of RNAi (RNA interference) technology in curing Chandipura virus infection in vitro and in vivo |
| Researcher: | Satyendra, Kumar |
| Guide: | Arankalle, Vidya A |
| Department: | National Institute of Virology |
| Publisher: | University of Pune |
| Place: | Pune |
| Year: | 2009 |
| Language: | English |
| Subject: | Virology | Biotechnology | Treatments | Protein | Drugs |
| Dissertation/Thesis Note: | PhD |
| Fulltext: | Shodhganga |
| 000 | 00000ntm a2200000ua 4500 | |
| 001 | 254762 | |
| 003 | IN-AhILN | |
| 005 | 2013-07-09 10:25:47 | |
| 008 | __ | 110902t2009||||ii#||||g|m||||||||||eng|| |
| 035 | __ | |a(IN-AhILN)th_254762 |
| 040 | __ | |aPUNE_411007|dIN-AhILN |
| 041 | __ | |aeng |
| 100 | __ | |aSatyendra, Kumar|eResearcher |
| 110 | __ | |aNational Institute of Virology|bUniversity of Pune|dPune |
| 245 | __ | |aEvaluation of RNAi (RNA interference) technology in curing Chandipura virus infection in vitro and in vivo |
| 260 | __ | |aPune|bUniversity of Pune|c2009 |
| 502 | __ | |bPhD |
| 520 | __ | |aIn parts of India, Chandipura Virus (CHPV) has emerged as an encephalitis causing pathogen in both epidemic and sporadic forms. This pediatric disease follows rapid course leading to 55-75% mortality. In the absence of specific treatment, effectiveness |
| 653 | __ | |aVirology |
| 653 | __ | |aBiotechnology |
| 653 | __ | |aTreatments |
| 653 | __ | |aProtein |
| 653 | __ | |aDrugs |
| 700 | __ | |aArankalle, Vidya A|eGuide |
| 856 | __ | |uhttp://shodhganga.inflibnet.ac.in/handle/10603/2609|yShodhganga |
| 905 | __ | |anotification |
User Feedback Comes Under This section.